Characteristics of repeat non‐attenders at Diabetes Eye Screening Wales, a national community‐based diabetes‐related retinopathy screening service, during 2003‐2018 by Becky, Thomas et al.
Diabetic Medicine. 2021;38:e14536.  wileyonlinelibrary.com/journal/dme  | 1 of 9
https://doi.org/10.1111/dme.14536
1 |  INTRODUCTION
Diabetes- related retinopathy is acknowledged to be one of the 
leading causes of blindness in the working age population in 
most countries with devastating personal and socio- economic 
consequences, despite being largely avoidable.1- 3 Since sys-
tematic screening was introduction in the early 2000s, it is 
no longer the primary cause of blindness in this population 
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Abstract
Aims: To understand factors associated with repeat non- attendance at screening for 
diabetes- related retinopathy.
Methods: Retrospective observational study using anonymised data from Diabetic 
Eye Screening Wales for people with a full history of screening invitations and at-
tendances was linked with primary and secondary care records held in the Secure 
Anonymised Information Linkage Databank. Repeat non- attendance was defined as 
no record of attendance during any 36- month period despite three cycles of annual 
screening invitations. The associations between repeat non- attendance and potential 
risk factors were examined using multivariable logistic regression analysis, stratified 
according to type 1 and type 2 diabetes.
Results: A total of 18% with type 1 diabetes (1146/6513) and 8% with type 2 diabe-
tes (12,475/156,525) were repeat non- attenders. Participants attending their very first 
appointment were least likely to become repeat non- attenders [odds ratio (95% con-
fidence interval)]: type 1 diabetes: 0.12 (0.09, 0.17) and type 2 diabetes: 0.08 (0.07, 
0.09). For both types of diabetes, those of a younger age, living in areas of higher 
deprivation and subject to multiple house moves were at greater risk of becoming 
repeat non- attenders.
Conclusion/interpretation: A more tailored approach is needed for the younger 
population, those living in areas of higher deprivation and/or undergoing multiple 
residential relocation and to ensure attendance at their initial appointment to minimise 
future repeat non- attendance.
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group in England and Wales.4 A 50% reduction in the inci-
dence of new certification for visual impairment and blind-
ness has been observed in Wales from 2007 to 2015.5
Despite the clinical and cost effectiveness benefits of 
retinal screening, a substantial number of people invited 
fail to attend.6 A high coverage is vital to reduce unneces-
sary visual loss and blindness due to diabetes; the current 
uptake rates in England and Wales are relatively stable at 
approximately 80%.6,7 Factors known to inhibit attendance 
at diabetic retinopathy screening include younger age, a 
lower socio- economic status, type of diabetes, age, eth-
nicity and poor glycaemic control.6- 14 In addition, confu-
sion between screening and standard eye tests, relevance 
of screening despite no visual symptoms, fear of screen-
ing (e.g. mydriasis), plus practical obstacles (e.g. cost, 
time, access), have also been identified as person- related 
barriers.12,13,15,16
2 |  METHODS
This retrospective observational study involved analysing an-
onymised linked electronic health records held in the Secure 
Anonymised Information Linkage Databank (Swansea 
University) from Diabetic Eye Screening Wales, primary 
care (Welsh Longitudinal General Practice) and secondary 
care (Patient Episode Database for Wales).
2.1 | Screening procedure in Wales
Within 3  months of diagnosis of diabetes, people aged 
12 years and over and registered with a general practitioner lo-
cated in Wales are referred to Diabetes Eye Screening Wales 
(previously known as the Diabetic Retinopathy Screening 
Service for Wales), a community- based national screen-
ing programme commissioned by the Welsh Government 
in 2003.17,18 Since 2018 Public Health Wales have become 
responsible for the screening service. A small number of in-
dividuals are excluded from screening on medical grounds, 
as well as those currently under the care of hospital eye ser-
vices for a diabetes- related reason, until they are discharged. 
A first appointment letter is dispatched which allows dates 
and venues to be altered for the person's convenience. For 
those who fail to respond to the initial closed invitation, an-
other open invitation is sent automatically within 3 months, 
requesting them to contact the screening centre to make an 
appointment. A text messaging or e-mail reminder service 
is also used where possible. Failure to attend and no contact 
with Diabetic Eye Screening Wales results in a letter to the 
relevant general practice. Each cycle of screening appoint-
ments occurs on an annual basis.
2.2 | Data acquisition, transfer and storage
Our data encompassed the entire screening history and 
changes in socio- demographic profile from the date peo-
ple with diabetes were added to the Diabetic Eye Screening 
Wales register, until study end date, 1 January 2018.
From Diabetic Eye Screening Wales records, we ex-
tracted: age, sex, type of diabetes, duration of diabetes and 
date of registration at baseline and date of screening at-
tendance and retinopathy grade, at each appointment. The 
Welsh Longitudinal General Practice database for primary 
care (which covers approximately 75% of the Welsh pop-
ulation), provided information on diagnoses, medications 
prescribed, laboratory test results19 as well as house moves 
and changes of general practice n. For secondary care, the 
Patient Episode Database for Wales, include inpatient and 
outpatient hospital records covering the whole of Wales 
since 199820; type of diabetes was extracted from this data-
base. The type of diabetes was confirmed using all three da-
tabases. The data were anonymised by the National Health 
Service Wales Informatics Service and then transferred to 
the Secure Anonymised Information Linkage databank for 
storage and processing as described elsewhere20 (Figure 
S1). In the databank, there is a unique person- based linkage 
of data across several data files.
2.3 | Statistical analysis
We present descriptive data as mean ± SD or n (%). SPSS 
v26 was used to conduct the statistical analysis.
Novelty statement
• What is already known? 
Age, socio- economic status, type of diabetes, eth-
nicity and diabetes glycaemic control influence at-
tendance at diabetic retinopathy screening.
• What this study has found? 
Risk of repeat non- attendance at screening events 
related to: Non- attendance at the first screening ap-
pointment; Younger age <35 years; Social depri-
vation; Frequent house moves.
• What are the clinical implications? 
As non- attendance at the initial diabetic retinopa-
thy screening appointment lessens subsequent at-
tendance, a more tailored education programme 
aimed at younger people with diabetes, those liv-
ing in higher deprivation areas and/or subject to 
changes in residence is needed.
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We adhered to the ‘Transparent Reporting of a multivariable 
prediction model for Individual Prognosis Or Diagnosis’ guide-
lines in the design of this study and reporting of the findings.21 
People with known diabetes, aged 12 years and over, registered 
with Diabetic Eye Screening Wales for 3 or more years were 
included in the analysis. The primary outcome was repeat non- 
attendance, defined as no record of attendance at Diabetic Eye 
Screening Wales following three consecutive annual invitations 
(closed and open invitations) during a 36- month period.22
People with type 1 and type 2 diabetes were analysed 
separately due to differences identified during our initial 
analysis, and the potential differences in risk factors for non- 
attendance for those with type 1 diabetes being skewed by the 
higher numbers of people with type 2 diabetes in the dataset.
Potential risk factors (covariates) for repeat non- attendance 
studied were: sex, age, attendance at first screening appoint-
ment, retinopathy status at first screening, socio- economic 
status (Welsh Index Multiple Deprivation, version 2011), 
smoking status, number of house moves (defined as a change 
in lower layer output area between screening invitations), 
number of changes in general practices and HbA1c. We also 
adjusted on the number of years since 2003 when participants 
were added to the Diabetic Eye Screening Wales registry, to 
control for changes in service delivery. Duration of follow- up 
was added as a covariate to adjust for a potential impact of 
unequal lengths of follow- up between participants.
2.3.1 | Initial data analysis
Characteristics of repeat non- attenders and attenders were 
compared using χ2 tests for categorical variables and t- 
tests for numeric variables. The percentages of repeat non- 
attendance between people with type 1 and type 2 diabetes 
were compared with a χ2 test.
2.3.2 | Model development
Multivariable logistic regression analysis was performed 
to study associations between non- attendance and potential 
causative factors. We used a stratified temporal 80:20 split 
sample for model development and validation, according to 
the date of registration with the screening programme. Dates 
of registration with Diabetic Eye Screening Wales were 
sorted chronologically; the development dataset included 
people before the 80th percentile split; the remaining 20% 
of data becoming the validation dataset. We aimed to see if 
the model developed on older data was appropriate for more 
recent data. The data were stratified by repeat non- attendance 
before splitting to ensure similar percentages of repeat non- 
attenders in the development and validation datasets.
We used a combination of variable selection processes, in-
cluding forward and backward stepwise selection, and compar-
ison of goodness of fit statistics (Snell R2and Nagelkerke R2) of 
candidate models to build the development model (Table S1).
Age was categorised according to a combination of liter-
ature review6,23 and clinical judgement. People with type 1 
diabetes older than 34 were combined into one group because 
there were too few people in the older age group. The young-
est age group (10– 17 years) was used as the reference for type 
1 diabetes whereas for type 2 diabetes, the cut- off points cho-
sen were 54 and 84 years, considered to be when changes in 
people's daily lives (employment pattern, availability of free 
time, prioritisation of health and social care needs) become 
more observable, with the oldest age group (≥85 years) serv-
ing as the reference group.
The fifth quintile of the Welsh Index Multiple Deprivation 
(least deprived areas) was used as the reference group for both 
type 1 and type 2 diabetes. HbA1c values were categorised 
into 10 mmol/mol or 1% bands before analysis. Calendar year 
is when individual participants were added to the Diabetic 
Eye Screening Wales registry; in the models we used years 
after the index year, 2003.
The continuous covariates: number of house moves per 
year, number of general practice changes per year, number 
of years from the time when screening service started and 
duration of eye screening follow- up were assessed for non- 
linearity by comparing models fitting them as linear term, 
quadratic or cubic terms. The combination of terms with best 
fit was chosen. If the model fit was similar, then the simplest 
model was chosen.
2.3.3 | Model performance on validation data
The model created in the development dataset was then ap-
plied to the validation dataset to test its performance. In the 
validation dataset, the predicted probability of repeat non- 
attendance was calculated using the coefficients from the 
development model. We examined every possible cut- off 
value along the whole range of the model's estimated risk 
of becoming a repeat non- attender using area under the re-
ceiver operating characteristic curve. Model discrimination 
was considered acceptable if area under the receiver operat-
ing characteristic curve was >0.7, 24 indicating that the ratio 
of the time when a repeat non- attender had a higher predicted 
probability than an attender to be >0.7.
People in the validation dataset were grouped into risk strata, 
based on the predicted probability of repeat non- attendance. 
Expected and observed rates of repeat non- attendance in each 
risk strata were compared to assess model calibration through 
the use of the Hosmer– Lemeshow test. A p > 0.05 indicates 
that a model is not significantly mis calibrated.
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3 |  RESULTS
People aged 12 years or more were invited for screening be-
tween 1 January 2003 and 1 January 2018. The mean ± SD 
follow- up time since registration for type 1 diabetes 
(n = 6513) was 6.3 ± 2.0 years and 6.2 ± 2.0 years for type 
2 diabetes (n = 156,525). Only those on the register for more 
than 3 years with a confirmed type of diabetes and who sur-
vived till the end of the follow- up period were included in 
the analysis (Figure S2). Failure to attend three consecutive 
annual screening appointments over a period of 36 months 
was more frequent in type 1 than type 2 diabetes 18% versus 
8.0% (p < 0.0001).
Characteristics of repeat non- attenders and attenders 
with type 1 and type 2 diabetes and the level of missing data 
are shown in Tables 1 and 2. In type 1 diabetes repeat non- 
attenders were more likely to be aged 18– 34 years, less likely 
to have attended their first screening invitation, live in more 
deprived areas and move house more frequently and have a 
higher HbA1c (81 vs. 73 mmol/mol [9.6 vs. 8.9%]) compared 
to attendees (Table 1). In type 2 diabetes repeat non- attenders 
were more likely to be aged 35– 54 years, and also less likely 
to attend the first screening invitation, live in more deprived 
areas and to have a higher HbA1c levels (65 mmol/mol [8.1%] 
vs. 58 mmol/mol [7.5%]) (Table 2).
We reviewed potential covariates for inclusion in the 
final model using the development dataset. For type 1 dia-
betes, the development model explained a modest amount 
of variability between repeat non- attenders and attenders 
(Cox and Snell R2 were 0.18; Nagelkerke R2 0.30). The 
regression equation derived from the development dataset 
was applied to the validation dataset for model validation, 
and the corresponding area under the curve was 0.87 (95% 
CI 0.84– 0.90). The Hosmer– Lemeshow statistic was 31.30, 
p = 0.0001.
Similarly, for type 2 diabetes, the development model ex-
plained a modest amount of variability between repeat non- 
attenders and attenders (Cox and Snell R2 0.13; Nagelkerke 
R2 0.29). The regression equation derived from the develop-
ment dataset was applied to the validation dataset for model 
validation, and the corresponding area under the curve was 
0.91 (95% CI 0.90– 0.91). The Hosmer– Lemeshow statistic 
was 977.29, p < 0.0001. Table 3 shows the odds ratios of the 
potential risk factors for both type 1 and type 2 diabetes with 
HbA1c in mmol/mol; HbA1c results in % units are shown in 
Table S3).
Based on the multivariable model, people with type 1 di-
abetes aged 18– 34 years were 37% more likely to miss three 
consecutive annual screening appointments compared to the 
reference group, aged 12– 17 years (Table 3). The most de-
prived (Welsh Index of Multiple Deprivation quintiles 1 and 
2) were 84% and 50%, respectively, more likely to be repeat 
non- attenders compared to those living in the least deprived 
area (Welsh Index of Multiple Deprivation 5). Every ad-
ditional house move per year would lead to 2.59 times in-
creased risk of repeat non- attendance. A major predictor of 
repeat non- attendance was failure to attend the first screening 
appointment whereas those attending were 88% less likely to 
become repeat non- attenders.
Women with type 2 diabetes were more likely than men 
to miss all three consecutive annual screening appointments 
(Table 3). Also, those who were younger were more likely 
to become repeat non- attenders with those aged 12– 17, 18– 
34 and 35– 54 years at 5.2, 2.3 and 1.4- fold increased risk of 
non- attendance, respectively when compared to those aged 
>84  years. In contrast, people with type 2 diabetes aged 
55– 84 years were 22% more likely to attend all three annual 
appointments. Those living in more deprived areas were 
significantly more likely to be repeat non- attenders and for 
every additional house move per year, the risk of becoming a 
repeat non- attender increased fourfold. The most significant 
predictor of being a repeat non- attender was failure to attend 
the first screening appointment: those attending their initial 
appointment were 92% more likely to attend all three consec-
utive annual screening appointments.
Unfortunately, the level of missing data was high for 
smoking status and HbA1c, for both type 1 and type 2 diabetes. 
Current smokers with type 1 and type 2 diabetes were 1.5 and 
1.6 times, respectively, more likely to be repeat non- attenders 
compared to those who provided no information on smoking 
(Table 3). When compared with those for whom no HbA1c 
information were available, those with type 1 diabetes with 
lower HbA1c (48– 78 mmol/mol, 6.5– 9.5%) were significantly 
less likely to be repeat non- attenders, although there was no 
significant difference for those with higher HbA1c levels. In 
people with type 2 diabetes when compared with those for 
whom no HbA1c information was available, those with HbA1c 
lower than 79 mmol/mol (9.5%) were significantly less likely 
to be repeat non- attenders and those with HbA1c higher than 
98 mmol/mol (10.5%) were 1.6 times more likely to be repeat 
non- attenders (Table  3; Table S2). Supplementary analysis 
was carried out excluding these two risk factors with similar 
results (Table S3).
4 |  DISCUSSION
Previous studies have demonstrated that the risk of devel-
oping sight- threatening diabetic retinopathy increases with 
increasing numbers of missed screening appointments.6,8 In 
our population, young age (18– 34 years), increasing depri-
vation and social mobility (house/residence) and especially 
non- attendance at first screening appointment were all pre-
dictors for repeated non- attendance for both type 1 and type 
2 diabetes. We observed for the first time, the very significant 
negative impact of missing the first screening appointment 
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T A B L E  1  For people with type 1 diabetes, demographic differences between those who attended (attenders) screening for diabetic retinopathy 
(n = 5367) and those who repeatedly did not (non- attenders) (n = 1146) over a 36- month period
Type 1 diabetes attenders
n = 5367
Type 1 diabetes non- attenders
n = 1146 p value
Sex, men 2993 (56%) 671 (59%) 0.09
Age (years) <0.0001
12– 17 1413 (26%) 207 (18%)
18– 34 1868 (35%) 575 (50%)
>34 2085 (39%) 364 (32%)
Missing 1 0
Attendance at first screening invitation 4409 (82%) 382(33%) <0.0001
Retinopathy status at first screening 0.51
No 2568 (48%) 212 (19%)
Background 1268 (24%) 103 (9.0%)
Maculopathy 83 (1.5%) 11 (1.0%)
Referable diabetic retinopathy 199 (3.7%) 18 (1.6%)
Missing 1249 (23%) 802 (70%)
Deprivation <0.0001
WIMD1 (most) 1173 (22%) 358 (31%)
WIMD2 1121 (21%) 288 (25%)
WIMD3 1150 (21%) 222 (19%)
WIMD4 969 (18%) 150 (13%)
WIMD5 (least) 933 (17%) 125 (11%)
Missing 21 (0.4%) 3 (0.3%)
Smoking status <0.0001
Non- smoker 2234 (42%) 153 (13%)
Smoker 1148 (21%) 148 (13%)
Missing 1985 (37%) 845 (74%)
Number of house moves/year 0.13 ± 0.18 0.20 ± 0.22 <0.0001
Number of general practice changes/year 0.15 ± 0.16 0.18 ± 0.18 <0.0001
HbA1c within 12 months of screening invitation <0.0001
mmol/mol 73 ± 20 81 ± 22
% 8.9 ± 1.8 9.6 ± 2.0
Missing 2340 (44%) 607 (53%)
Calendar year when added to diabetic eye screening register <0.0001
2003 117 (2.2%) 14 (1.2%)
2004 271 (5.0%) 36 (3.1%)
2005 508 (9.5%) 78 (6.8%)
2006 670 (12%) 126 (11%)
2007 685 (13%) 106 (9.3%)
2008 1322 (25%) 527 (46%)
2009 314 (5.9%) 71 (6.2%)
2010 354 (6.6%) 66 (5.8%)
2011 259 (4.8%) 46 (4.0%)
2012 244 (4.5%) 29 (2.5%)
2013 268 (5.0%) 23 (2.0%)
2014 202 (3.8%) 13 (1.1%)
2015 153 (2.9%) 9 (0.8%)
Duration of diabetic eye screening Wales follow- up (years) 6.30 ± 2.05 6.49 ± 1.82 0.002
Note: Data are presented as n (%) or mean ± SD.
Variables with missing data are shown, along with the number of missing values.
Abbreviations: WIMD, Welsh Index Multiple Deprivation (version 2011).
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T A B L E  2  For people with type 2 diabetes, demographic differences between those who attended (attenders) screening for diabetic retinopathy 
(n = 144,050) and those repeatedly who did not (non- attenders) (n = 12,475) over a 36- month period
Type 2 diabetes attenders
n = 144,050
Type 2 diabetes non- attenders
n = 12,475 p value
Sex, men 81,651 (57%) 6461 (52%) <0.0001
Age (years) <0.0001
12– 17 46 (0.0%) 19 (0.2%)
18– 34 2311 (1.6%) 747 (6.0%)
35– 54 32,307 (22%) 4868 (39%)
55– 84 105,558 (73%) 6465 (52%)
>84 3798 (2.6%) 369 (3.0%)
Missing 30 (0.0%) 7 (0.1%)
Attendance at first screening invitation 131,370 (91%) 4931 (40%) <0.0001
Retinopathy status at first screening 0.12
No 93,220 (65%) 3422 (27%)
Background 28,167 (20%) 1054 (8.4%)
Maculopathy 702 (0.5%) 31 (0.2%)
Referable diabetic retinopathy 1691 (1.2%) 80 (0.6%)
Missing 20,270 (14%) 7888 (63%)
Deprivation <0.0001
WIMD1 (most) 31,407 (22%) 3915 (31%)
WIMD2 30,795 (21%) 3013 (24%)
WIMD3 30,225 (21%) 2382 (19%)
WIMD4 27,460 (19%) 1870 (15%)
WIMD5 (least) 23,903 (17%) 1274 (10%)
Missing 290 (0.2%) 21 (0.2%)
Smoking status <0.0001
Non- smoker 73,078 (51%) 2194 (18%)
Smoker 34,578 (24%) 1948 (16%)
Missing 36,394 (25%) 8363 (67%)
Number of house moves/year 0.05 ± 0.12 0.11 ± 0.16 <0.0001
Number of general practice changes/year 0.12 ± 0.14 0.15 ± 0.16 <0.0001
HbA1c within 12 months of screening invitation <0.0001
mmol/mol 58 ± 17 65 ± 23
% 7.5 ± 1.6 8.1 ± 2.2
Missing 55,795 (39%) 5941 (48%)
Calendar year when added to diabetic eye screening Wales 
register
<0.0001
2003 2201 (1.5%) 136 (1.1%)
2004 6364 (4.4%) 421 (3.4%)
2005 12,567 (8.7%) 763 (6.1%)
2006 18,597 (13%) 1149 (9.2%)
2007 19,540 (14%) 1182 (9.5%)
2008 21,723 (15%) 4292 (34%)
2009 10,403 (7.2%) 1014 (8.1%)
2010 10,381 (7.2%) 889 (7.1%)
2011 9819 (6.8%) 808 (6.5%)
2012 9350 (6.5%) 688 (5.5%)
2013 9309 (6.5%) 568 (4.6%)
2014 8208 (5.7%) 369 (3.0%)
2015 and 6a 5588 (3.9%) 196 (1.6%)
(Continues)
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Type 2 diabetes attenders
n = 144,050
Type 2 diabetes non- attenders
n = 12,475 p value
Duration of diabetic eye screening Wales follow- up (years) 6.24 ± 2.09 6.01 ± 1.91 <0.0001
Note: Data are presented as n (%) or mean ± SD.
Variables with missing data are shown, along with the number of missing values.
WIMD, Welsh Index Multiple Deprivation (version 2011).
aCell count in 2016 < 5, reported together with 2015. 
TABLE 2 (Continued)
T A B L E  3  Odds ratios (95% confidence intervals) from multivariable logistic regression models for the risk of repeated non- attendance at 





Sex Removed from model
Men Reference
Women 1.25 (1.19, 1.31)
Age (years)
Type 1 Type 2
12– 17 12– 17 Reference 5.16 (2.34,11.34)
18– 34 18– 34 1.37 (1.07, 1.74) 2.35 (1.97,2.81)
>34 35– 54 0.91 (0.71, 1.17) 1.41 (1.23, 1.61)
55– 84 0.78 (0.68, 0.89)
>84 Reference
Attendance at first screening invitation 0.12 (0.09, 0.17) 0.08 (0.07, 0.09)
Deprivation
WIMD 1 (most) 1.84 (1.40, 2.42) 1.76 (1.63, 1.91)
WIMD 2 1.50 (1.13, 1.98) 1.52 (1.40, 1.65)
WIMD 3 1.23 (0.92, 1.64) 1.29 (1.18, 1.40)
WIMD 4 1.00 (0.73, 1.37) 1.19 (1.09, 1.30)
WIMD 5 (least) Reference Reference
Smoking status
Missing Reference Reference
Non smoker 0.90 (0.63, 1.27) 0.97 (0.88, 1.06)
Smoker 1.53 (1.07, 2.20) 1.56 (1.42, 1.72)
Number of house moves/year 2.59 (1.70, 3.96) 4.15 (3.53, 4.88)
HbA1c (mmol/mol) within 12 months of screening invitation
Missing Reference Reference
≤48 0.92 (0.56, 1.53) 0.87 (0.81, 0.94)
49−58 0.67 (0.45, 0.99) 0.64 (0.59, 0.69)
59– 68 0.54 (0.40, 0.74) 0.63 (0.58, 0.69)
69– 78 0.63 (0.48, 0.84) 0.80 (0.73, 0.89)
79– 88 1.04 (0.77, 1.40) 0.99 (0.88, 1.11)
89– 98 1.27 (0.89, 1.79) 1.02 (0.89, 1.16)
99– 108 1.26 (0.82, 1.94) 1.50 (1.28, 1.75)
≥109 1.12 (0.74, 1.71) 1.64 (1.40, 1.91)
Number of years since 2003 when added to screening registry 3.53 (2.59, 4.82) 2.56 (2.40, 2.74)
[Number of years since 2003 when added to screening registry]2 0.88 (0.85, 0.91) 0.92 (0.91, 0.92)
Duration of diabetic eye screening Wales follow- up (years) 2.34 (1.74, 3.14) 1.94 (1.78, 2.11)
[Duration of diabetic eye screening Wales follow- up (years)] 2 0.94 (0.92, 0.96) 0.92 (0.91, 0.92)
Abbreviation: WIMD, Welsh Index Multiple Deprivation (version 2011).
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and frequent changes in residence. Additionally, women with 
type 2 diabetes were more likely to be repeat non- attenders.
The strength of this study is that it is derived from a 
national community- based diabetic retinopathy screening 
programme with a high coverage (~80%) of people with dia-
betes who are eligible for screening. The study benefits from 
its longitudinal nature and the ability to link Diabetic Eye 
Screening Wales and other electronic health record data from 
primary and secondary care. We adopted a logistic model to 
understand the relationship between repeat non- attendance 
and potential risk factors; we checked the performance of our 
models with temporal validation and found that though they 
showed some miscalibration, model discrimination was ex-
cellent. This study was retrospective, the current analytical 
models developed may not apply to future data and therefore 
will require further recalibration to improve the model fit. 
Whereas logistic models provide a good understanding of the 
underlying relationships between repeat non- attendance and 
potential risk factors it may be possible in the future to exter-
nally validate the model with a different population. The use 
of routine data also has its limitations due to missing infor-
mation which here was especially true for smoking status and 
HbA1c. We tried to limit the bias of missing data
23 which can 
cause an overestimation of the precision of the prediction, 
although the magnitude of the coefficients in our models 
showed this to be unlikely. In addition, further analysis with-
out HbA1c or smoking status, found a similar pattern of risk 
factors, again making the possibility of overestimation un-
likely. Another limitation of the study was that only approx-
imately 75% of the Welsh population (Welsh Longitudinal 
General Practice) was available for inclusion in the analysis.
Younger age and living in higher deprivation areas have 
previously been identified as risk factors for non- attendance 
at eye screening in people with diabetes.6,8,14,25 A diabetic 
retinopathy screening programme in England is currently 
evaluating an education programme delivered in paediatric 
diabetes clinics to address this problem.26 Other methods such 
as inviting children and young people with diabetes to visit 
a screening clinic prior to receiving their first appointment 
could also be employed. However, further enhancement in 
the education of parents/carers of children and young people 
with diabetes to better understand the importance and need 
for screening is required.27 Leaflets to promote screening in 
young adults with type 2 diabetes developed by Lake et al28 
could easily be made available to general practice, paediatric 
and adult secondary care clinics.
The finding of increasing deprivation having a negative 
impact on attendance is not a new observation for diabetic 
retinopathy screening programmes.7,9 However, it is ac-
knowledged that tackling health inequalities is complex and 
extends beyond health care.29
In summary, we confirm the sub- optimal screening up-
take in the younger population with diabetes. However, our 
findings that non- attendance at the first screening event and 
a higher level of house moves may offer in part an explana-
tion for the pattern of repeat non- attendance. The importance 
of attending the first screening appointment should not be 
underestimated. Also changing residence is particularly rel-
evant to the younger and more mobile population with dia-
betes who are leaving home to pursue further education or 
employment in new areas.
It is therefore vital that health care professionals and policy-
makers continue the quest to better understand the barriers to 
screening and adjust future management procedures to ensure 
attendance at future screening invitations in an attempt to pre-
vent the development of sight- threatening diabetic retinopathy 
and blindness in our vulnerable population with diabetes.
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